spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

Tag: FDA Expands Roflumilast Use for Atopic Dermatitis to Children Aged 2 to 5 Years

FDA Expands Roflumilast Use for Atopic Dermatitis to Children Aged 2 to 5 Years

The FDA has approved roflumilast cream 0.05% (Zoryve; Arcutis Biotherapeutics) for children aged 2 to 5 years, meaning that...